5 key notes on Stryker stock after director sells another 12k shares

Spinal Tech

Stryker Director Ronda Stryker sold 12,000 company shares yesterday worth around $1.2 million, according to an OctaFinance report.

In the last month, Ms. Stryker sold around 132,000 shares valued at around $13.12 million. She now owns 25.96 million shares, worth around 6.81 percent of the company's total market cap.

 

Here are five things to know:

 

1. Unloading the shares could mean Ms. Stryker expects the stock price to decline. More than 20 top stock analysts following the company listed the EPS expectations at $5.10 with a price-earnings ratio of 19.77.

 

2. There are 37 investment managers with Stryker stock in their Top 10, with Greenleaf Trust as the most positive institutional investor, according to the report. Greenleaf owned 29.02 million shares at the end of last year, 79.26 percent of the business.

 

3. The institutional ownership was 72 percent of the stock's outstanding shares in the fourth quarter of 2014, which decreased by 7.85 million total shares they hold. The institutional investors owned 271.5 million as of that quarter.

 

4. A year-over-year growth rate of less than 9.02 percent is forecasted.

 

5. OctaFinance gave Stryker stock a "neutral" rating after taking Ms. Stryker's sale into account, with the stock price up 23.34 percent over the past 200 days.

 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers